home All News open_in_new Full Article

VIH : qui pourra se payer le nouveau traitement révolutionnaire ?

L'Europe a autorise cet ete la commercialisation du lenacapavir, un traitement preventif contre le virus du sida. Mais son prix, 28 000 dollars par patient et par an, cree toujours la polemique.


today 37 h. ago attach_file Science

attach_file Science
attach_file Science
attach_file Transport
attach_file Sport
attach_file Politics
attach_file Politics
attach_file Science
attach_file Politics
attach_file Events
attach_file Science
attach_file Events
attach_file Sport
attach_file Science
attach_file Science
attach_file Economics
attach_file Society
attach_file Society
attach_file Events
attach_file Events
attach_file Science


ID: 1917748022
Add Watch Country

arrow_drop_down